Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05067816 · ClinicalTrials.gov registry record · NA
Med-South Lifestyle Program Implementation Study
A NA study of Healthy Lifestyle, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 368
- Enrollment target
- 1
- Study location
NCT05067816: Completed NA study of Healthy Lifestyle, sponsored by University of North Carolina, Chapel Hill.
NCT05067816 is a NA study of Healthy Lifestyle that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 368 participants, above the 213-participant average among 16 other Healthy Lifestyle trials with a reported enrollment target (73% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05067816, a NA study of Healthy Lifestyle, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 368 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the processes by which a previously proven lifestyle intervention (the Med-South Lifestyle Program) can most effectively and efficiently be translated into public health and clinical practice to positively impact chronic disease risk reduction among mostly minority, rural, and medically underserved populations.
Primary Outcome
Percentage of each setting's eligible patients who participate in the Med-South Lifestyle Program and the representativeness of participants (age, gender, race/ethnicity) as compared to overall population of eligible patients.
Conditions Studied
Interventions
- BEHAVIORAL Med-South Lifestyle Program
Study Locations (1)
North Carolina
- UNC Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2021-10-26 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
What the finished NCT05067816 record still lists
NCT05067816 is an interventional study that assigns participants to a tested intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap, above the 213-participant average among 16 other Healthy Lifestyle trials with a reported enrollment target (73% higher).
The record links to 1 condition, with Healthy Lifestyle appearing as the primary indexed condition, and to 1 intervention - of which Med-South Lifestyle Program is the first listed.
NCT05067816 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05067816 about?
NCT05067816 is a clinical study titled "Med-South Lifestyle Program Implementation Study". The purpose of this study is to determine the processes by which a previously proven lifestyle intervention (the Med-South Lifestyle Program) can most effectively and efficiently be translated into public health and clinical practice to positively impact chronic disease risk reduction among mostly m...
What is the current status of trial NCT05067816?
This trial is currently completed. It is a NA study. The enrollment target is 368 participants. The study started on 2021-10-26. Estimated completion is 2024-02-01.
What conditions does trial NCT05067816 study?
This clinical trial studies the following conditions: Healthy Lifestyle.
What interventions are being tested in trial NCT05067816?
The interventions under investigation include: Med-South Lifestyle Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05067816?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05067816 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Lifestyle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05067816's enrollment target sits among peer trials
368 2nd of 16 the highest of 16 other Healthy Lifestyle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Lifestyle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Neurophysiological Markers of Brain Health
RECRUITING · NA
-
A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study
RECRUITING · NA
-
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
RECRUITING · NA
-
Families Implementing Good Health Traditions for Life
RECRUITING · NA
-
Personalized Health Self-Management Training for Colorectal Cancer Survivors
RECRUITING · NA
-
Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI